Home > Company List > Financial Reports
Euro-Med Laboratories Phil., Inc.
Information in this page will become available upon submission of the Company of its latest financial statements. To view previous financial statements of the Company, kindly proceed to the Company's page in the PSE Main website (http://www.pse.com.ph).
For the fiscal year ended : Dec 31, 2021
Currency(and units, if applicable) : Php
| Item | Current Year | Previous Year |
|---|---|---|
| Current Assets | 3,910,877,748 | 4,312,026,063 |
| Total Assets | 9,691,407,221 | 10,071,636,206 |
| Current Liabilities | 2,937,366,673 | 3,833,431,833 |
| Total Liabilities | 4,050,729,720 | 4,623,811,529 |
| Retained Earnings/(Deficit) | 1,493,715,455 | 1,324,669,954 |
| Stockholders' Equity | 5,640,677,501 | 5,447,824,677 |
| Stockholders' Equity - Parent | 5,563,817,961 | 5,352,551,907 |
| Book Value Per Share | 1.37 | 1.32 |
| Item | Current Year | Previous Year |
|---|---|---|
| Gross Revenue | 1,513,931,486 | 1,650,298,705 |
| Gross Expense | 1,282,521,386 | 1,345,268,068 |
| Income/(Loss) Before Tax | 231,410,100 | 305,030,637 |
| Net Income/(Loss) After Tax | 169,045,501 | 210,050,212 |
| Net Income/(Loss) Attributable to Parent | 211,266,054 | 201,242,861 |
| Earnings/(Loss) Per Share (Basic) | 0.05 | 0.05 |
| Earnings/(Loss) Per Share (Diluted) | 0.05 | 0.05 |
For the period ended : Mar 31, 2022
Currency(and units, if applicable) : Php
| Item | Period Ended | Fiscal Year Ended(Audited) |
|---|---|---|
| Current Assets | 3,774,737,211 | 3,910,877,748 |
| Total Assets | 9,539,827,671 | 9,691,407,221 |
| Current Liabilities | 2,836,670,977 | 2,937,366,673 |
| Total Liabilities | 3,612,921,444 | 3,726,117,140 |
| Retained Earnings/(Deficit) | 1,456,623,769 | 1,493,715,455 |
| Stockholders' Equity | 5,603,585,815 | 5,640,677,501 |
| Stockholders' Equity - Parent | 1,388,643,937 | 1,419,893,038 |
| Book Value Per Share | 1.36 | 1.37 |
| Item | Current Year (3 Months) | Previous Year (3 Months) | Current Year-To-Date | Previous Year-To-Date |
|---|---|---|---|---|
| Gross Revenue | 305,935,970 | 330,379,203 | 305,935,970 | 330,379,203 |
| Gross Expense | 267,993,024 | 289,705,242 | 267,993,024 | 289,705,242 |
| Income/(Loss) Before Tax | 37,942,946 | 40,673,961 | 37,942,946 | 40,673,961 |
| Net Income/(Loss) After Tax | 27,382,246 | 29,929,139 | 27,382,246 | 29,929,139 |
| Net Income/(Loss) Attributable to Parent | 27,382,246 | 29,929,139 | 27,382,246 | 29,929,139 |
| Earnings/(Loss) Per Share (Basic) | 0.01 | 0.01 | 0.01 | 0.01 |
| Earnings/(Loss) Per Share (Diluted) | 0.01 | 0.01 | 0.01 | 0.01 |
